BEN YONG (Chief Med & Dev Officer) reported 1 transaction at BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/5/2026ACC: 0001193125-26-207041
Officer· Chief Med & Dev Officer
Since Mar 2026
-1.05K
Net shares
Net seller
$9.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.05K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.05K
Price / share
$9.03
Trade value
$9.45K
% of position
2.2%
4/1/2026
46.67K→45.62K
Total
Net shares
−1.05K
Net value
-$9.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | F · Tax Withholding | −1.05K | $9.03 | $9.45K | 2.2% | 46.67K | 45.62K |
| Total | −1.05K | -$9.45K | ||||||
Derivative Transactions0
No derivative transactions reported